[HTML][HTML] Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

A Babu, N Amreddy, R Muralidharan, G Pathuri… - Scientific reports, 2017 - nature.com
In this study, we report the efficacy of RGD (arginine-glycine-aspartic acid) peptide-modified
polylactic acid-co-glycolic acid (PLGA)-Chitosan nanoparticle (CSNP) for integrin αvβ3 …

[HTML][HTML] Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

A Babu, N Amreddy, R Muralidharan, G Pathuri… - Scientific …, 2017 - ncbi.nlm.nih.gov
In this study, we report the efficacy of RGD (arginine-glycine-aspartic acid) peptide-modified
polylactic acid-co-glycolic acid (PLGA)-Chitosan nanoparticle (CSNP) for integrin α v β 3 …

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

A Babu, N Amreddy, R Muralidharan… - Scientific …, 2017 - pubmed.ncbi.nlm.nih.gov
In this study, we report the efficacy of RGD (arginine-glycine-aspartic acid) peptide-modified
polylactic acid-co-glycolic acid (PLGA)-Chitosan nanoparticle (CSNP) for integrin α v β 3 …

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

A Babu, N Amreddy, R Muralidharan, G Pathuri… - Scientific Reports, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> In this study, we report the efficacy of RGD
(arginine-glycine-aspartic acid) peptide-modified polylactic acid-co-glycolic acid (PLGA) …

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.

A Babu, N Amreddy, R Muralidharan, G Pathuri… - Scientific …, 2017 - europepmc.org
In this study, we report the efficacy of RGD (arginine-glycine-aspartic acid) peptide-modified
polylactic acid-co-glycolic acid (PLGA)-Chitosan nanoparticle (CSNP) for integrin α v β 3 …

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

A Babu, N Amreddy, R Muralidharan… - Scientific …, 2017 - ui.adsabs.harvard.edu
In this study, we report the efficacy of RGD (arginine-glycine-aspartic acid) peptide-modified
polylactic acid-co-glycolic acid (PLGA)-Chitosan nanoparticle (CSNP) for integrin α v β 3 …

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.

A Babu, N Amreddy, R Muralidharan, G Pathuri… - Scientific …, 2017 - europepmc.org
In this study, we report the efficacy of RGD (arginine-glycine-aspartic acid) peptide-modified
polylactic acid-co-glycolic acid (PLGA)-Chitosan nanoparticle (CSNP) for integrin α v β 3 …